1. The fractional rate of prc'tein synthesis (FSR) in tissues of nine growing lambs (4-5 months of age) was estimated following continuous infusion of ~-[4,5-*H]leucine for a period of 7 h. Minimum and upper estimates of FSR were obtained assuming that the specific radioactivity (SRA) of leucine in blood plasma and tissue homogenate respectively defined that of leucyl tRNA. 3. Plasma leucine flux was c.osely related to body protein content and dietary leucine absorption (r 0.94).
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of several hours is a technique which has been extensively used to measure rates of protein synthesis in animal tissues, largely because of the simplicity of the calculations required (see Waterlow et al. 1978) . This method was adopted for the present study using ~-[4,5-~H]leucine as tracer amino acid. Leucine was chosen from those amino acids which meet the criteria required (see Nicholas et al. 1978; Waterlow et al. 1978) mainly for reasons of analytical expediency.
The quantitative validity of results obtained from the use of the continuous infusion technique is still open to debate (see Lobley & Harris, 1977; Waterlow et af. 1978) . However, it is at least possible to estimate upper and lower limits to the rates of protein synthesis in individual tissues.
The lambs used in the present experiment were part of a comparative slaughter trial investigating the effect of abomasal casein infusion on the rate of protein deposition in growing lambs given fresh ryegrass (Lolium perenne) ad fib. (Barry, 1981) .
M E T H O D S
Animals
Nine autumn-born, castrate male, Romney lambs were used. At the start of the experiment these animals were approximately 5 months of age and weighed approximately 16-0 kg. ~-[4,5-~H]leucine was infused into three lambs at this stage and in the remaining six animals the infusions were carried out 11 weeks later. The latter six lambs had abomasal fistulas inserted at 4 months of age and three lambs were infused with casein (44 g sodium caseinate plus 0.5 g L-methionine/d) and three with an equivalent volume of salt solution (containing sodium chloride and sodium hydrogen phosphate) over the 1 1-week experimental period, as reported by Barry (1981) .
All lambs were housed individually in pens, offered fresh ryegrass/clover (Trifolium repens) pasture ad lib, and intakes (as dry matter (DM)) recorded daily. Approximately 1 week before the continuous infusion of leucine the lambs were transferred to metabolism crates and intake measured over the final 4 d of this period. All other management procedures were as reported by Barry (1981) .
Infusion procedure
On the day before leucine infusion jugular catheters were inserted bilaterally into each lamb. The infusion catheter (250 mm) was twice the length of the catheter used for blood sampling in order to prevent the direct sampling of infusate.
~-[4,5-~H]leucine (40-60 mCi/mmol ; batch no. 71, obtained from The Radiochemical Centre, Amersham, Bucks., UK) was diluted in 200 ml saline (9 g NaCl/l) and infused at a rate of approximately 100 pCi/h. All lambs were allowed access to fresh herbage ad lib. during the leucine infusion and, where appropriate, casein or control salt solutions were infused into the abomasum.
Tissue and blood sampling Before the end of each infusion (approximately 7 h) the lamb was anaesthetized with sodium pentobarbitone and samples (approximately 5 g) of shaved skin and skeletal muscle (longissimus dorsi, biceps femoris) removed by biopsy. The infusion was stopped and the lamb killed by severing the blood vessels of the neck. Samples were then taken of rumen, liver and cardiac muscle. All tissue samples were frozen immediately in liquid nitrogen and stored at -20° until analysed. Following slaughter all tissue samples were removed within a 3 min period.
Blood samples (10 ml) were taken at 20 min intervals for the first 2 h of infusion and every 30 min thereafter. Samples were kept on ice in heparinized tubes and the plasma harvested within 2 h and stored at -20° until analysis.
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Analytical techniques Specijic radioactivity (SRA) of leucine in tissues andplasma. All SRA determinations were carried out on leucine fractionated by ion-exchange chromatography on a JEOL-6AH amino acid analyser (JEOL Co Ltd, Tokyo, Japan). Chromatography was carried out on a 500 mm column (9 mm diameter) containing JEOL-LCR-2 resin (sulphonated polystyrene beads, 10-11 pm diameter). Each analysis was performed at a buffer flow rate of 0.95 ml/min using 0.2 M-sodium citrate buffer, pH 4-2, at a column temperature of 55'. This procedure gave 'near baseline' separation of isoleucine, leucine, norleucine and tyrosine, and the leucinecontaining fraction was collected by split-streaming the column eluate such that approximately half was diverted to a fraction collector while the remainder was reacted with ninhydrin for determination of leucine mass. Each complete analysis (including column regeneration) took 120 min.
Preparation of tissues. Frozen tissue samples were cooled in liquid N,, pulverized, and homogenized in 8 ml tric hloracetic acid (100 g/l; TCA) containing 0.5 pmol norleucine. The homogenate was centrifuged for 5 min at 750g and the supernatant decanted. The precipitate was washed three times with 5ml TCA and the washings added to the supernatant fraction. The washed precipitate was freeze-dried and a portion of t h s material (100 mg) hydrolysed for 24 h in 6 M-hydrochloric acid (50 ml) under reflux. Following hydrolysis, 5 mg norleucine was added to each tiask and the hydrolysate rotary evaporated under vacuum to near dryness, washed three times with water, re-constituted in 100 ml of water and stored at -20' before fractionation on the amino acid analyser. The final volume for reconstitution was reduced for some tissues to increase the concentration of radioactivity in the sample. In these instances the ion-exchange column was overloaded with amino acid and, of the fraction collrxted, part was used for determination of 3H content and part was re-analysed for leucine mass.
The supernatant fraction containing tissue free amino acids was extracted three times with 10 ml diethyl ether to remove excess TCA, rotary evaporated and re-constituted in 3.0 ml 0-01 M-HCI.
Plasma samples. Plasma was deproteinized with an equal volume of sulphosalicyclic acid (60 g/l) containing 0.1 umol norleucine. Approximately 0.8 ml plasma equivalent was analysed as described pi-eviously for determination of leucine SRA.
Determination of radioactivity. The fractions containing radioactive leucine collected from the amino acid analyser were bulked, rotary evaporated to dryness, re-constituted in 1 ml water and transferred to a scintillation vial. The flask used for evaporation was rinsed thoroughly with 10 ml :scintillation fluid ('Aquasol'; New England Nuclear, USA) and added to the vial and sz.mple.
Radioactivity was determined by liquid-scintillation spectrometry in a Tracor 6890 liquid-scintillation counter at a counting efficiency of 30-35 % (determined by external standard channels ratio:g.
Radiochemical purity
~-[4,5-~H]leucine (batch no. 71) had a quoted D-leucine content of less than 1 %. Although this was not verified further the relatively constant plateau specific activity of leucine achieved in plasma wotld suggest that D-leucine, if present, was not accumulating with consequences to the accuracy of determination of FSR and plasma leucine flux (see Waterlow et al. 1978) . Purity of the leucine was determined by fractionating the original infusate solution on the amino acid analyser as described previously. Recovery of 95% of the loaded radioactivity was made with the leucine-containing fraction. Part of this fraction was re-analysed to determine analytical 1os:;es and recovery was found to be 100% 412 where I the rate of infusion of isotope (pCi/h), F is the flux (mmol/h) and S, is the plateau SRA of leucine in plasma (,uCi/mmol).
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Protein FSR. The FSR in the tissues was calculated as described by Garlick et al. (1973) from the formula;
-e-kJ
where SB is the SRA of protein-bound leucine and S, the SRA of 'free' (homogenate) leucine in the tissues, k, is the FSR (/d), t is the length of infusion (d) and A, is the rate-constant describing the rise to plateau of the SRA of free leucine in the tissue.
Because A, was not determined directly the approximations of Garlick et al. (1973) were used such that for muscle A,.= Rk,, where R is the concentration ratio, protein-bound leucine: free leucine in the tissue. For skin, liver and rumen At = A, , where A, is the rateconstant in the formula describing the rise to plateau of leucine SRA in plasma (S,) as;
where S , max is the plasma leucine plateau SRA and t is the length of infusion (d).
Because the calculation of k, is relatively insensitive to variation in A, the average A, determined in the nine animals was used. This value was A, = 39 /d.
In view of the uncertainty relating to how closely 'free' leucine SRA (S,) equates with the SRA of leucyl tRNA (see Lobley & Harris, 1977) an estimate of the FSR was calculated using equation no. 2 but substituting S,:S, for SB:Si. The estimate of k, so derived will be referred to as the minimum FSR.
Leucine absorption from the small intestine. The rate of leucine absorption from the small intestine was calculated from the results of Macrae & Ulyatt (1974) relating duodenal
Leucine absorption from the small intestine was estimated assuming 75 g leucine/kg crude protein (D. NAN x 6-25) in the duodenal digesta and an apparent absorption of 0.73 (Macrae & Ulyatt, 1974) . Where applicable, the additional contribution of the sodium caseinate infusate (44*0g/d) to the duodenal leucine flow was calculated assuming a casein-leucine content of 101 g/kg protein (Ling et al. 1961) . The apparent absorption of casein-leucine was assumed to be 0.73.
(3) RESULTS
Food intake, body protein content and plasma leucine flux Plasma leucine SRA rose rapidly to a maximum in all animals; the rate constant (A,) describing the rise to plateau was 39/d (determined on combined data from the nine lambs). The plateau leucine SRA was calculated as the mean of SRA determinations on samples taken between 2 h and 7 h of infusion. The coefficient of variation of plateau leucine SRA varied from 7-24% in individual lambs (Table 1) .
Plasma leucine flux was closely related to predicted leucine absorption (r 0.93; P c 0.01) and to body protein content (r 0.88; P < 0.01). Bivariate regression analysis of plasma leucine flux (mmol/d) against predicted leucine absorption (mmol/d; XI) and body protein t Calculated from dry-matter intake using conversion factors of 0.68 g digestible organic matter (DOM)/g organic matter and 16.3 kJ/g DOM (see Barry, 1981) and including contribution of casein infusate where applicable.
After 2 h of infusion. content (kg; X,) showed that these factors accounted for 88% of the variation in plasma leucine flux between animals (r 0.94) as described by the equation
However, body protein content and predicted leucine absorption were also significantly correlated ( r 048; P < 0.01) and therefore the individual contribution of these two variables to leucine flux cannot be estimated with confidence from the regression analysis.
On the assumption that increments in leucine absorbed from the intestine contribute equally to the plasma leucine flux it may be calculated that, on average, there was a contribution of 63 mmol leucine/d from the diet to the plasma leucine flux of 129 mmol/d ( Table 1) . However, the correlation of plasma leucine flux, corrected for dietary input, with total body protein content deteriorated by adopting this procedure (r 0.8 1) although still statistically significant (P < 0.01).
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Free leucine in tissues andplasma
The mean SRA of leucine extracted from the tissue homogenate vaned from 26% (rumen) to 75% (heart) of the plateau leucine SRA in plasma ( Table 2 ). The 'free' leucine concentration was always greater in tissues than in plasma, ranging up to a sixfold difference in the rumen wall (Tables 2 and 1) .
The plasma concentration of leucine was higher in the casein-infused lambs than in the control-infused lambs but was similar to that found in the initial control group (Table 1) .
The value for 'free' leiicine SRA: plasma leucine SRA (Si: S,; Table 2 ) tended to increase with increasing dietary leucine absorption but the correlation only achieved statistical significance (P < 0.05) in skin, liver and heart tissues.
Tissue protein FSR
The FSR of protein in the sampled tissues is shown in Table 3 . Highest values for FSR were determined in liver and rumen but between lamb variability was also greatest in these tissues.
The mean minimum estimate of FSR (see p. 412) for each tissue is also shown in Table 3 . The greatest difference between the minimum and upper estimates of FSR were found in liver, rumen and skin.
Tissue protein FSR was not related to predicted leucine absorption from food, the rate of protein deposition or plasma leucine flux, neither were there any marked differences between the treatment groups.
Estimate of whole-body protein synthesis from FSR measurements
The rate of protein synthesis in an individual tissue was calculated as the product of FSR and protein content ( Table 4) (Table 2 ) weighted for the contribution each makes to the total protein mass. This value was then corrected for an extracellular fluid content of 20%. the SRA of leucine in the latter being assumed to be equivalent to that in plasma. Whole-body protein synthesis (WBS) was calculated assuming a leucine content in body protein of 70g/kg protein and using the plasma leucine flux protein was not sampled necessitating assumptions to be made as to the FSR of protein in these tissues (see Table 4 ).
WBS was calculated using the upper and minimum estimates of tissue protein FSR, the former estimate of WBS being almost three times that of the latter ( Table 4) . The contribution of skeletal muscle to total daily protein synthesis was a relatively small percentage (12) of the total (using the upper estimates of FSR) while skin and intestinal protein together contributed over 50% of the total.
Estimate of whole-body protein synthesis from plasma leucine flux The calculation of WBS directly from the plasma leucine flux is questionable because part of the plasma flux may contribute to oxidative pathways and because an unknown fraction of the leucine released by protein degradation is reincorporated into protein without passing through the plasma pool (localized recycling). Such errors act in opposite directions (Garlick et al. 1976), but still a high extent of uncertainty is left in the final answer.
The estimate of WBS derived from plasma leucine flux directly (240 g/d; see Fig. 1 ) was similar to that derived previously using the minimum estimate of FSR (see Table 4 ). Thus the uncertainty which applies to the flux estimate of WBS casts doubt on accuracy of the estimate derived from minimum FSR. A further calculation of WBS from the plasma leucine flux corrected for the contribution of the flux to oxidative pathways and for the extent of localized recycling is summarized schematically in Fig. 1 . The result obtained from applying such corrections (WBS 610 g/d) was considerably greater than that obtained directly from the flux, but similar to that derived using the upper estimate of FSR. 
DISCUSSION
Tissue protein FSR Studies of the rate of protein turnover in ovine tissues are summarized in Table 5 . All these studies differ in the live weight of the animals used or methodology, particularly in the choice of the radioactive amino acid used for infusion, or both. The values obtained for tissue protein FSR were considerably greater than the present results for comparable tissues. Whether these discrepancies reflect dietary, methodological or environmental differences is unknown. Arnal (1977) reported that tissue protein FSR declined in lambs up to 16 weeks of age and at this stage of development the FSR of muscle protein was similar to that found in the present experiments.
The estimates of FSR for liver and rumen protein are compromised to the extent that the liver 'exports' a largc: part of its protein production and the rumen epithelium will lose whole cells by sloughing during the processes of digestion. Such phenomena will result in anunderestimateofFSRandprobablycontribute to thevariability ofthe FSRdeterminations in these tissues. Further, measurements of protein synthesis in tissues where protein turnover is rapid (e.g. gut and liver) are subject to error when the continuous infusion technique is used because of loss of labelled protein by turnover during the period of infusion (James er al. 1971). The technique described by McNurlan et al. (1979) is more suitable for tissues such as the gut and liver but is prohibitively expensive for use in large animals because of the massive quantity of radioactive amino acid required. Millward, Garlick & Reeds (1976) suggested that the primary regulation of muscle protein content in rats is achieved through regulation of protein synthesis. This could not be confirmed in the present study as protein deposition (in the six lambs where it was measured) and protein FSR were not correlated. Failure to demonstrate such a correlation probably relates to the insensitivity of the technique. When the rate of protein deposition (20-30 g/d; Table 1 ) is such a small proportion of the rate of protein synthesis (600 g/d; Table 4 ) only a small change in the latter will result in large changes in the rate of deposition if the rate of degradation remains constant. A similar sensitivity of protein deposition to the rate of degradation also applies.. Nevertheless, the increase in plasma insulin concentration as a consequence of casein infusion (Barry et al. 1981) may reduce the rate of proteolysis in muscle (see Trenkle, 1!)74) and thus the increased rate of protein deposition in the casein-infused animals may be attributable, in part, to a reduced rate of protein degradation. It has been suggested that leucine is rate-limiting for protein synthesis in rat muscle (Buse & Weigand, 1977) . The results reported here do not support this contention for the skeletal muscles but there was a significant relationship between cardiac muscle leucineconcentration 418 S. ll. DAVIS, T. N. B A R R Y A N D G. A. HUGHSON and cardiac protein FSR (r 0-81; P < 0.01). Morgan et al. (1971) have demonstrated an increase in rate of peptide chain initiation in isolated perfused rat hearts in association with an increased concentration of leucine in the perfusate.
The estimate of WBS
The use of plasma amino acid flux to calculate the rate of WBS has been discussed elsewhere (Reeds & Lobley, 1980) . The estimate of WBS obtained from plasma leucine flux, adjusted for oxidative losses and localized recycling (610 g/d; Fig. 1 ) was similar to that obtained from the upper estimate of tissue protein FSR (581 g/d; Table 4 ).
The validity of both higher values of WBS is dependent on how closely the estimates of homogenate leucine SRA (S,) and intracellular leucine SRA (Fig. I) relate to the SRA of leucyl tRNA. The relative merits of using S, or S , to determine tissue protein FSR have been discussed by Lobley & Harris (1977) . The closer S, approaches S, the greater the confidence that may be placed in the final result. In the present study S , : S , varied from 0.26 (rumen) to 0.75 (heart) thereby posing the question as to which factor is an accurate reflection of leucyl tRNA SRA.
There is good reason to doubt the accuracy of calculating WBS from plasma amino acid flux uncorrected for oxidation or localized recycling. The similarity of this value to the estimate of WBS derived from the minimum estimate of FSR suggests that the latter is also in error. The evidence of Airhart et al. (1974) and Fern & Garlick (1974) S, : S, increased with increasing leucine absorption from the diet in all tissues, although the correlation only achieved statistical significance in skin, rumen and heart. Such a relationship, however, infers that the contribution of plasma leucine to the leucine pool for protein synthesis increases with increasing nutritional status, this phenomenon tending to diminish the difference between S, and Si. Further evidence in support of this contention is that increments in leucine absorption from food result in larger increments in plasma leucine flux (see p. 412) suggesting an increased exchange of leucine between tissues and plasma with increasing food intake. However, confirmation of this finding is required using animals of similar body protein content but differing widely in food intake.
The energy cost of protein turnover
The energy cost of protein deposition in lambs increases with the transition from the preruminant to ruminant state (Rattray & Jagusch, 1977) . The energy cost of protein turnover in the digestive tract of the ruminant might be expected to be greater than in the non-ruminant because of the relatively large muscle mass of the rumen and the high FSR of its protein (Table 3) . A point worthy of consideration in relation to the FSR of rumen protein is whether the latter is associated with the muscle or epithelial layers and to what extent the protein synthesized utilizes amino acids from rumen fluid. The rumen has not been regarded as a major site of amino acid absorption (Leibholz, 1969) but recycling of amino acids between the rumen wall and rumen contents may occur to an appreciable extent. 
